S Pallanti

Summary

Affiliation: Mount Sinai School of Medicine
Country: Italy

Publications

  1. ncbi request reprint Relapse in young paranoid schizophrenic patients: a prospective study of stressful life events, P300 measures, and coping
    S Pallanti
    Institute for Neurosciences, Florence, Italy
    Am J Psychiatry 154:792-8. 1997
  2. ncbi request reprint Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines
    Stefano Pallanti
    Mount Sinai School of Medicine, New York, New York, USA
    Prog Neuropsychopharmacol Biol Psychiatry 30:400-12. 2006
  3. ncbi request reprint Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study
    Stefano Pallanti
    Institute for Neurosciences, Florence, Italy
    J Clin Psychiatry 65:1394-9. 2004
  4. ncbi request reprint Social anxiety in outpatients with schizophrenia: a relevant cause of disability
    Stefano Pallanti
    Department of Neurological and Psychiatric Sciences, University of Florence, Italy
    Am J Psychiatry 161:53-8. 2004
  5. ncbi request reprint Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial
    Stefano Pallanti
    Istituto di Neuroscienze, and University of Florence, School of Medicine, Italy
    J Clin Psychiatry 63:796-801. 2002
  6. ncbi request reprint Treatment non-response in OCD: methodological issues and operational definitions
    Stefano Pallanti
    Mount Sinai School of Medicine, New York, NY, USA
    Int J Neuropsychopharmacol 5:181-91. 2002
  7. ncbi request reprint Eye movement abnormalities in anorexia nervosa
    S Pallanti
    Istituto di Neuroscienze and University of Florence Medical School, Italy
    Psychiatry Res 78:59-70. 1998
  8. ncbi request reprint Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder
    S Pallanti
    Neurosciences Institute, Florence, Italy
    Am J Psychiatry 156:1094-6. 1999
  9. ncbi request reprint The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation
    S Pallanti
    Istituto di Neuroscienze, University of Florence Medical School, Italy
    J Clin Psychiatry 60:819-23. 1999
  10. ncbi request reprint Effects of clozapine on awareness of illness and cognition in schizophrenia
    S Pallanti
    Istituto di Neuroscienze, Centro di Neurologia, Psichiatria e Psicologia Clinica S r l, Florence, Italy
    Psychiatry Res 86:239-49. 1999

Detail Information

Publications40

  1. ncbi request reprint Relapse in young paranoid schizophrenic patients: a prospective study of stressful life events, P300 measures, and coping
    S Pallanti
    Institute for Neurosciences, Florence, Italy
    Am J Psychiatry 154:792-8. 1997
    ..The authors investigated the relationship of cognitive and coping characteristics to stressful life events at the time of relapse in patients with recent-onset paranoid schizophrenia...
  2. ncbi request reprint Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines
    Stefano Pallanti
    Mount Sinai School of Medicine, New York, New York, USA
    Prog Neuropsychopharmacol Biol Psychiatry 30:400-12. 2006
    ..The authors reviewed also the more recent therapeutic pharmacological and psychological lines for the treatment of refractoriness in OCD...
  3. ncbi request reprint Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study
    Stefano Pallanti
    Institute for Neurosciences, Florence, Italy
    J Clin Psychiatry 65:1394-9. 2004
    ..The present study was undertaken to determine whether the mirtazapine-citalopram combination could induce an earlier and/or greater effect on the 5-HT system in OCD subjects than citalopram alone...
  4. ncbi request reprint Social anxiety in outpatients with schizophrenia: a relevant cause of disability
    Stefano Pallanti
    Department of Neurological and Psychiatric Sciences, University of Florence, Italy
    Am J Psychiatry 161:53-8. 2004
    ....
  5. ncbi request reprint Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial
    Stefano Pallanti
    Istituto di Neuroscienze, and University of Florence, School of Medicine, Italy
    J Clin Psychiatry 63:796-801. 2002
    ..The selective serotonin reuptake inhibitor citalopram is effective for OCD when administered orally. We investigated whether intravenous citalopram would rapidly benefit OCD patients unresponsive to orally administered SRIs...
  6. ncbi request reprint Treatment non-response in OCD: methodological issues and operational definitions
    Stefano Pallanti
    Mount Sinai School of Medicine, New York, NY, USA
    Int J Neuropsychopharmacol 5:181-91. 2002
    ..Better characterization of which patients respond and do not respond to various treatments will enable more accurate clustering of patients, and help facilitate multi-site data collection for future research trials...
  7. ncbi request reprint Eye movement abnormalities in anorexia nervosa
    S Pallanti
    Istituto di Neuroscienze and University of Florence Medical School, Italy
    Psychiatry Res 78:59-70. 1998
    ..Results are in agreement with the hypothesis regarding the persistence of neurophysiological as well as psychopathological traits of disorder in anorectic patients...
  8. ncbi request reprint Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder
    S Pallanti
    Neurosciences Institute, Florence, Italy
    Am J Psychiatry 156:1094-6. 1999
    ..The authors' goal was to investigate the awareness of illness and subjective cognitive complaints of patients with either bipolar I disorder or bipolar II disorder during a phase of clinical stabilization...
  9. ncbi request reprint The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation
    S Pallanti
    Istituto di Neuroscienze, University of Florence Medical School, Italy
    J Clin Psychiatry 60:819-23. 1999
    ..The atypical neuroleptic clozapine has been reported to induce anxiety symptoms, probably owing to its effect on serotonergic pathways. We report 12 cases of schizophrenic patients who developed social phobia during clozapine treatment...
  10. ncbi request reprint Effects of clozapine on awareness of illness and cognition in schizophrenia
    S Pallanti
    Istituto di Neuroscienze, Centro di Neurologia, Psichiatria e Psicologia Clinica S r l, Florence, Italy
    Psychiatry Res 86:239-49. 1999
    ..The results confirm the effectiveness of clozapine not only in enhancing neurocognitive function, but also in increasing awareness of illness in schizophrenic patients...
  11. doi request reprint Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response
    S Pallanti
    Department of Psychiatry, Mount Sinai School of Medicine, Bronx, New York, NY, USA
    Neuropsychobiology 65:227-35. 2012
    ..We investigated the clinical, cognitive and neurophysiologic effects of a 3 weeks' protocol of low-frequency rTMS applied over the right DLPFC in resistant depression...
  12. pmc The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
    S Bernardi
    Department of Psychiatry, Columbia University New York State Psychiatric Institute, New York, NY, USA
    Psychol Med 42:875-87. 2012
    ....
  13. doi request reprint Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study
    Stefano Pallanti
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
    CNS Drugs 23:1047-55. 2009
    ..Trial registration number (ClinicalTrials.gov): NCT00796497...
  14. doi request reprint Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview
    R Valenti
    Department of Neurological and Psychiatric Sciences, University of Florence, Italy
    Acta Neurol Scand 124:390-5. 2011
    ..Although recognized as a cardinal feature of the disease, psychiatric disturbances have rarely been the object of focused studies. We performed a structured evaluation of mood disorders in CADASIL...
  15. ncbi request reprint Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study
    Eric Hollander
    Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
    Int J Neuropsychopharmacol 6:397-401. 2003
    ..Risperidone may be an effective and well-tolerated augmentation strategy in treatment-resistant OCD subjects, but larger sample size studies are required to demonstrate this...
  16. doi request reprint Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression?
    S Pallanti
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Neuroscience 167:323-8. 2010
    ..To confirm and extend these findings further studies require a longer follow-up period, supported by biological observation and replication...
  17. ncbi request reprint Refractory obsessive-compulsive disorder: state-of-the-art treatment
    Eric Hollander
    Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 63:20-9. 2002
    ..The authors synthesize state-of-the-art treatment and give practical advice for clinicians...
  18. ncbi request reprint Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patients
    Monte S Buchsbaum
    Mount Sinai School of Medicine, New York, NY 10029, USA
    Neuropsychobiology 53:157-68. 2006
    ..Our results are consistent with a frontostriatal circuit change related to both dopaminergic and serotonergic systems and with the presence of psychopharmacological subtypes within OCD...
  19. doi request reprint Autoimmune markers in vitiligo patients appear correlated with obsession and phobia
    S Moretti
    Department of Critical Care Medicine and Surgery, Division of Dermatology, University of Florence, Florence, Italy
    J Eur Acad Dermatol Venereol 26:861-7. 2012
    ....
  20. ncbi request reprint Emotional arousal and phobia in transient global amnesia
    D Inzitari
    Department of Neurological and Psychiatric Sciences, University of Florence, Italy
    Arch Neurol 54:866-73. 1997
    ..To evaluate the role of emotionally stressful or phobogenic events and phobic personality traits in transient global amnesia (TGA)...
  21. ncbi request reprint Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
    Eric Hollander
    Compulsive, Impulsive, and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Am J Psychiatry 162:137-45. 2005
    ..To the authors' knowledge, this is the first placebo-controlled treatment study in pathological gamblers with bipolar spectrum disorders; it compares sustained-release lithium carbonate to placebo...
  22. ncbi request reprint A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder
    Stefano Pallanti
    Department of Psychiatry, University of Florence, Italy
    J Clin Psychiatry 65:6-10. 2004
    ..More results are needed before the effectiveness of the nonpharmacologic treatments for OCD can be determined...
  23. doi request reprint Cognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms
    Stefano Pallanti
    Institute for Neurosciences, Viale Ugo Bassi, Firenze 50137, Italy
    Psychiatry Res 170:52-60. 2009
    ..Neurobiological underpinnings deserve further considerations and might drive to a definition of a distinctive endophenotype for schizo-OCD in the de-construction of the schizophrenia endophenotype...
  24. ncbi request reprint Lithium and valproate treatment of pathological gambling: a randomized single-blind study
    Stefano Pallanti
    Mount Sinai School of Medicine, New York, NY, USA
    J Clin Psychiatry 63:559-64. 2002
    ..The aim of the present study was to evaluate the efficacy and safety of lithium and valproate in nonbipolar pathological gamblers...
  25. ncbi request reprint Quality of life and clinical characteristics of patients with generalized and performance-focused social anxiety disorder: An Italian study
    S Pallanti
    Department of Neuropsychiatric Sciences, University of Florence, Florence, Italy
    Int J Psychiatry Clin Pract 12:256-60. 2008
    ..Conclusions. GSAD is associated with widespread worsening of QoL, while patients with PFSAD had a poorer QoL than controls only in the areas of physical health and leisure time. ..
  26. ncbi request reprint Attachment processes in eating disorders
    A Ramacciotti
    Istituto di Neuroscienze, , Italy
    Eat Weight Disord 6:166-70. 2001
    ..An inference is none the less made with regard to the role of psychotherapy in these results...
  27. ncbi request reprint Detecting attention-deficit/hyperactivity disorder (ADHD) in adults with intellectual disability The use of Conners' Adult ADHD Rating Scales (CAARS)
    G La Malfa
    Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy
    Res Dev Disabil 29:158-64. 2008
    ..Therefore, not only can ADHD be a valid psychiatric diagnosis for a child with ID but for an adult with ID as well. The CAARS can be considered a useful clinical instrument to survey ADHD in ID...
  28. ncbi request reprint Obsessive-compulsive disorder spectrum as a scientific "metaphor"
    Stefano Pallanti
    Strategic Center of Excellence of Psychiatry, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
    CNS Spectr 13:6-15. 2008
    ..By increasing research in this field, the OCD spectrum may evolve from a fragmented level of conceptualization as a "metaphor" to one that is more comprehensive and structured...
  29. ncbi request reprint Nefazodone treatment of pathological gambling: a prospective open-label controlled trial
    Stefano Pallanti
    Department of Psychiatry, Mount Sinai School of Medicine, New York, N Y, USA
    J Clin Psychiatry 63:1034-9. 2002
    ....
  30. ncbi request reprint Pharmacological treatments of pathological gambling
    Eric Hollander
    Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, Box 1230, One Gustave L Levy Place, New York, NY, USA
    J Gambl Stud 21:99-110. 2005
    ..This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies...
  31. ncbi request reprint Internet addiction: a descriptive clinical study focusing on comorbidities and dissociative symptoms
    Silvia Bernardi
    Department of Psychiatry, Mount Sinai School of Medicine, Manhattan, NY, USA
    Compr Psychiatry 50:510-6. 2009
    ..The detachment has been suggested as a reason for the attractiveness of the Internet; thus, we assessed dissociative symptoms and their association with IAD disability...
  32. ncbi request reprint Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS)
    Stefano Pallanti
    Mount Sinai School of Medicine, New York, NY 10029, USA
    J Gambl Stud 21:431-43. 2005
    ..PG-YBOCS thus appears to be a reliable and valid measure of pathological gambling severity, and can be regarded as an important tool for clinicians and researchers treating pathological gamblers...
  33. doi request reprint Bipolar disorder and comorbid attention deficit hyperactivity disorder. A distinct clinical phenotype? Clinical characteristics and temperamental traits
    Silvia Bernardi
    Department of Psychiatry, Mount Sinai School of Medicine, New York 10029, USA
    World J Biol Psychiatry 11:656-66. 2010
    ..We further hypothesize that maladaptive temperament will be associated with the severity of both illnesses...
  34. ncbi request reprint Brain plasticity and brain stimulation in neuropsychiatry: toward individualized medicine
    Stefano Pallanti
    Strategic Center of Excellence of Psychiatry, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
    CNS Spectr 13:287-92. 2008
  35. ncbi request reprint The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the assessment of multiple addictions in a high-school population: prevalence and related disability
    Stefano Pallanti
    Department of Psychiatry, Institute for Neuroscience, Florence University of Medicine, Florence, Italy
    CNS Spectr 11:966-74. 2006
    ....
  36. doi request reprint Neurobiology of repeated transcranial magnetic stimulation in the treatment of anxiety: a critical review
    Stefano Pallanti
    Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY 10029, USA
    Int Clin Psychopharmacol 24:163-73. 2009
    ..The neurobiological correlates suggest possible efficacy for the treatment of social anxiety that still has to be investigated...
  37. ncbi request reprint Kleptomania: clinical features and comorbidity in an Italian sample
    Silvio Presta
    Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Via Roma 67, 56100 Pisa, Italy
    Compr Psychiatry 43:7-12. 2002
    ..Family history also showed a high prevalence of psychiatric disorders. Our study indicates clear connections between kleptomania and different psychiatric disorders, the exact nature of which has yet to be clarified...
  38. doi request reprint Transcultural observations of obsessive-compulsive disorder
    Stefano Pallanti
    Am J Psychiatry 165:169-70. 2008
  39. ncbi request reprint [Validity and reliability of Quality of Life, Enjoyment and Satisfaction Questionnaire, Short Form]
    Paola Rucci
    Deipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotechnologie, Universita di Pisa
    Epidemiol Psichiatr Soc 16:82-9. 2007
  40. ncbi request reprint Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder
    Naomi A Fineberg
    Postgraduate School of Medicine, University of Hertfordshire, Hatfield, Herts, UK
    Int Clin Psychopharmacol 22:313-22. 2007
    ..Viewed collectively, these results suggest that selective serotonin reuptake inhibitors are effective long-term treatments and relapse prevention represents the treatment target for obsessive-compulsive disorder...